NFQ Level
Level 8
Teaching Mode
Part-Time
Duration
8 weeks of Lectures
This program introduces students to the molecular and cellular basis of diseases and how they influence the design and manufacturing of biological therapies. The course emphasizes protein and vaccine-based treatments and explores emerging gene and cell therapies along with personalized treatments.
Key Takeaways:
- Comprehensive introduction to molecular and cellular biology as it pertains to diseases
- Deep dive into protein and vaccine-based therapies, plus emerging gene and cell therapies
- Focus on large-scale drug and vaccine manufacturing processes
Why Choose this Course?
- Expert Collaboration: Jointly designed by UCC’s School of Biochemistry and Cell Biology and BioPharmaChem Skillnet.
- Industry-Relevant: Specifically tailored for those aiming to enter or upskill in BioPharma.
- Industry-Experienced Faculty: Delivered by experienced lecturers and industry experts.
- Up-to-Date Content : Introduces students to key fundamentals of biomanufacturing and novel biotherapeutics.
Course Structure and Content
Module: BC5007 Introduction to BioPharmaceuticals and Advanced Personalized Therapies
- Part 1 – focusses on the design and manufacture of protein BioPharmaceuticals and looks at regulated upstream and downstream processes.
- Part 2 – covers future medicines that are already beginning to revolutionize disease treatment and facilitate the delivery of personalized therapies, including gene therapies, advanced vaccine therapies and cell-based therapies – demystifying the terminology and introducing the concepts
Both course delivery and continuous assessment facilitated online
Entry Requirements
Educational Background:
- NFQ Level 8 qualification required.
- A quota allocated for those without formal qualifications but significant industry experience.
Application Materials:
- Application statement, birth certificate or passport, photograph, CV, language test report (if applicable), and transcripts.
;
